Skip to main content

Table 1 Characteristics of malaria episodes

From: Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

  N = 15,228
Age (years) N = 15,225
 Mean ± SD 8.9 ± 13.3
 Median [range] 3 [1–90]
Age by class N = 15,225
 ≤1 month 2 (<0.01%)
 2–11 months 2111 (13.9%)
 1–5 years 7740 (50.8%)
 6–13 years 2581 (17.0%)
 ≥14 years 2791 (18.3%)
Gender N = 15,225
 Female 7582 (49.8%)
 Male 7643 (50.2%)
Weight (kg) N = 15,221
 Mean ± SD 21.6 ± 18.9
 Median [range] 13 [2–116]
Weight by class (kg) N = 15,221
 <4.5 35 (0.2%)
 4.5 to <9 2704 (17.8%)
 9 to <18 7241 (47.6%)
 18 to <36 2278 (15.0%)
 ≥36 2963 (19.5%)
Clinical signs and symptomsa N = 15,225
 Fever 13,294 (87.3%)
 Hyperthermia 1608 (10.6%)
 Asthenia 1373 (9.0%)
 Chills 244 (1.6%)
 Headache 3005 (19.7%)
 Dizziness 228 (1.5%)
 Vomiting 2316 (15.2%)
 Diarrhoea 589 (3.9%)
 Abdominal pain 316 (2.1%)
 Decreased appetite/anorexia 2901 (19.1%)
 Joint ankylosis 1223 (8.0%)
 Anaemia 273 (1.8%)
Parasitaemia N = 14,634
 Positive thick blood smears 11,192 (76.5%)
  1. The N numbers in italics refer to the number of episodes for which the variable of interest was documented
  2. aFrequency counts correspond to number of episodes, since the same patient may have experienced more than one episode. Certain symptoms documented from self-report, such as pain, headache and dizziness, could not be ascertained in young children